BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26315540)

  • 1. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
    Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
    Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus.
    Fan W; Wei B; Chen X; Zhang Y; Xiao P; Li K; Zhang YQ; Huang J; Leng L; Bucala R
    Arthritis Res Ther; 2024 Jan; 26(1):31. PubMed ID: 38243295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity.
    Ibrahim MRK; Waly NG; Moness H; Ahmed SS; Ibrahem R
    Mol Biol Rep; 2023 Dec; 50(12):10025-10036. PubMed ID: 37904010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-98-5p Inhibits IFI44L-Mediated Differentiation of Dendritic Cells and Activation of Interferon Pathway in Systemic Lupus Erythematosus.
    Huang X; Tan Y; Wu R; Li Q; Luo S
    Immunol Invest; 2024 Apr; 53(3):475-489. PubMed ID: 38198612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus.
    Dominguez-Gutierrez PR; Ceribelli A; Satoh M; Sobel ES; Reeves WH; Chan EK
    Arthritis Res Ther; 2014 Jan; 16(1):R20. PubMed ID: 24451065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-Dimensional Chromosomal Landscape Revealing miR-146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR-Mediated Approach to Inhibit the Interferon Pathway.
    Zhu X; Zhang Y; Yin Z; Ye Z; Qin Y; Cheng Z; Shen Y; Yin Z; Ma J; Tang Y; Ding H; Guo Y; Hou G; Shen N
    Arthritis Rheumatol; 2024 Mar; 76(3):384-395. PubMed ID: 37728419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma microparticles from patients with systemic lupus erythematosus modulate the content of miRNAs in U937 cells.
    Carmona-Pérez L; Rojas M; Muñoz-Vahos C; Vanegas-García A; Vásquez G
    Immunology; 2021 Oct; 164(2):253-265. PubMed ID: 34003488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus.
    Fan W; Wei B; Chen X; Zhang Y; Xiao P; Li K; Zhang YQ; Huang J; Leng L; Bucala R
    Res Sq; 2023 Sep; ():. PubMed ID: 37790522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferon in the pathogenesis of systemic lupus erythematosus.
    Postal M; Vivaldo JF; Fernandez-Ruiz R; Paredes JL; Appenzeller S; Niewold TB
    Curr Opin Immunol; 2020 Dec; 67():87-94. PubMed ID: 33246136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE.
    Gómez-Bañuelos E; Goldman DW; Andrade V; Darrah E; Petri M; Andrade F
    Cell Rep Med; 2024 May; 5(5):101569. PubMed ID: 38744279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options.
    Strauß R; Rose T; Flint SM; Klotsche J; Häupl T; Peck-Radosavljevic M; Yoshida T; Kyogoku C; Flechsig A; Becker AM; Dao KH; Radbruch A; Burmester GR; Lyons PA; Davis LS; Hiepe F; Grützkau A; Biesen R
    J Mol Med (Berl); 2017 Jul; 95(7):753-765. PubMed ID: 28357476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.
    Renaudineau Y; Charras A; Natoli V; Fusaro M; Smith EMD; Beresford MW; Hedrich CM;
    Clin Immunol; 2024 May; 262():110194. PubMed ID: 38508295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of monocyte-associated biomarkers in systemic lupus erythematosus and their pan-cancer analysis.
    Chen H; He J; Wang L; Lin Y; Mou Z; Huang X; Chen L
    Lupus; 2023 Oct; 32(12):1369-1380. PubMed ID: 37769649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic and proteomic profiling reveals distinct pathogenic features of peripheral non-classical monocytes in systemic lupus erythematosus.
    Stergioti EM; Manolakou T; Sentis G; Samiotaki M; Kapsala N; Fanouriakis A; Boumpas DT; Banos A
    Clin Immunol; 2023 Oct; 255():109765. PubMed ID: 37678715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA-sequencing of peripheral blood mononuclear cells reveals widespread, context-specific gene expression regulation upon pathogenic exposure.
    Oelen R; de Vries DH; Brugge H; Gordon MG; Vochteloo M; ; ; Ye CJ; Westra HJ; Franke L; van der Wijst MGP
    Nat Commun; 2022 Jun; 13(1):3267. PubMed ID: 35672358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crucial regulatory role of type I interferon in inflammatory diseases.
    Ji L; Li T; Chen H; Yang Y; Lu E; Liu J; Qiao W; Chen H
    Cell Biosci; 2023 Dec; 13(1):230. PubMed ID: 38124132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a.
    Hao Y; Zhao W; Chang L; Chen X; Liu C; Liu Y; Hou L; Su Y; Xu H; Guo Y; Sun Q; Mu L; Wang J; Li H; Han J; Kong Q
    Immunol Lett; 2023 Nov; 263():133. PubMed ID: 36801115
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a" [Immunology Letters 250 (2022) 29-40 on Sep 13, 2022/ Manuscript ID: IMLET-D-22-00159R2, PMID: 36108773].
    Hao Y; Zhao W; Chang L; Chen X; Liu C; Liu Y; Hou L; Su Y; Xu H; Guo Y; Sun Q; Mu L; Wang J; Li H; Han J; Kong Q
    Immunol Lett; 2024 May; ():106866. PubMed ID: 38796353
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12 in Individuals of European Ancestry.
    Demirci FY; Wang X; Kelly JA; Morris DL; Barmada MM; Feingold E; Kao AH; Sivils KL; Bernatsky S; Pineau C; Clarke AE; Ramsey-Goldman R; Vyse TJ; Gaffney PM; Manzi S; Kamboh MI
    Arthritis Rheumatol; 2016 Jan; 68(1):174-83. PubMed ID: 26316170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetics of systemic lupus erythematosus: A comprehensive review.
    Ghodke-Puranik Y; Niewold TB
    J Autoimmun; 2015 Nov; 64():125-36. PubMed ID: 26324017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.